BioStem Technologies Inc. (BSEM) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for BioStem Technologies Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$1.51
+2.03% today
Market cap
$28M
Overall quality
54/100
Kronos AI 30-day
+154.4%
8 of 8 simulated paths end higher
BioStem Technologies Inc. (BSEM) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $28M. It trades at $1.51, up 2.03% today. Its overall quality score is 54 out of 100, ranked against the whole US market. 1 analysts' average target of $7.00 implies +363.6% from today's price. Kronos AI's 30-day forecast is +154.4% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $7.00 |
| Low – high | $7.00 – $7.00 |
| Analysts | 1 |
| Upside to average | +363.6% |
Kronos AI 30-day forecast
| Expected close | $3.77 (+154.4%) |
| Likely range | +134.8% … +178.2% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 39 |
| Solvency | 87 |
| Growth | 35 |
| Overall | 54 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.